Methanandamide increases COX-2 expression and tumor growth in murine lung cancer.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 17, Issue 14, 2003, Pages 2157-2159

  Gardner, Brian ^a   Zhu, L X ^a   Sharma, Sherven ^a   Tashkin, Donald P ^a   Dubinett, Steven M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (5 (4 CHLOROPHENYL) 3 (TRIFLUOROMETHYL) 1H PYRAZOL 1 YL)BENZENESULFONAMIDE; 4-(5-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; CYCLOOXYGENASE 2; ISOENZYME; METHANANDAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; LUNG TUMOR; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SPLEEN;

ANIMALS; ARACHIDONIC ACIDS; CELL DIVISION; CYCLOOXYGENASE 2; DINOPROSTONE; ISOENZYMES; LUNG NEOPLASMS; MICE; MODELS, BIOLOGICAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RECEPTORS, CANNABINOID; SPLEEN; SULFONAMIDES;

MLCS; MLOWN;

EID: 0642273057     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.03-0254fje     Document Type: Article

References (0)